Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-19 convalescent plasma produced by HEMOPE
RBR-7jqpnwPhase 3Not yet recruiting
- Sponsor
- Universidade de Pernambuco
- Start
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of COVID-19 convalescent plasma in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Universidade de Pernambuco. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
COVID-19 convalescent plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-7jqpnw.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7jqpnw.